age
greatest
challeng
healthcar
system
deal
centuri
wide
spectrum
patholog
impair
emerg
later
part
human
life
cours
sharpli
increas
mortal
reduc
qualiti
life
dysfunct
immun
system
advanc
age
crucial
import
develop
disabl
later
life
final
death
understand
immun
age
immunosenesc
long
recognis
essenti
prerequisit
deliveri
effect
intervent
improv
late
life
health
ten
year
ago
imagin
consortium
undertook
broad
rang
seri
project
ad
significantli
understand
fundament
age
mechan
drove
immun
declin
decad
follow
abund
evid
accumul
nonhuman
model
system
age
result
progress
oper
rel
common
process
act
across
major
organ
system
advanc
fundament
understand
allow
better
clarif
potenti
crosssystem
dysregul
occur
age
open
new
avenu
intervent
cours
workshop
origin
imagin
particip
consid
issu
present
suggest
current
prioriti
area
immunosenesc
great
triumph
public
health
nineteenth
twentieth
centuri
public
sanit
understand
caus
infecti
diseas
togeth
applic
discoveri
produc
epidemiolog
transit
mark
reduct
mortal
earli
part
life
cours
due
sharp
fall
death
acut
infecti
diseas
follow
rise
mortal
morbid
result
chronic
degen
condit
result
larger
number
individu
surviv
later
life
wilmoth
latest
censu
data
uk
show
proport
popul
age
drop
centuri
later
offic
nation
statist
period
proport
older
peopl
age
trebl
trend
set
continu
estim
popul
western
world
pacif
rim
age
lutz
et
al
age
associ
increas
suscept
wide
rang
degen
condit
rang
serious
trivial
fatal
healthcar
system
develop
deal
primarili
ill
children
young
adult
eg
earli
life
infecti
diseas
trauma
face
challeng
reorient
address
disord
later
life
ill
cost
money
reduc
qualiti
life
suffer
challeng
pose
age
popul
twenti
first
centuri
thu
avoid
nightmar
combin
steep
increas
health
spend
overal
reduct
qualiti
life
grow
proport
popul
resourc
implic
deal
age
popul
consider
larger
invest
histor
need
improv
earli
life
health
public
health
measur
respons
demograph
transit
cheap
cutler
miller
contrast
estim
total
budget
british
nation
health
servic
deploy
combat
poor
health
consequ
age
summerfield
babb
within
overal
cost
hospitalis
due
infect
much
common
elderli
younger
individu
major
contributor
develop
disabl
old
peopl
caljouw
et
al
howev
studi
rand
corpor
futur
medic
advanc
might
benefit
elderli
show
potenti
exist
new
treatment
fraction
cost
current
avail
goldman
et
al
estim
type
highlight
potenti
benefit
better
understand
fundament
biolog
basi
age
process
necess
exploit
knowledg
gain
far
product
better
late
life
intervent
age
evolv
implic
immun
system
whilst
identifi
age
level
popul
organ
rel
uncompl
increas
agespecif
mortal
underli
gompertz
relationship
hirsch
peretz
definit
age
work
well
individu
member
popul
prove
littl
contenti
age
often
defin
lesser
capac
maintain
homeostasi
condit
physiolog
stress
compar
younger
counterpart
comfort
thu
increas
likelihood
death
older
human
condit
cold
increas
likelihood
death
older
yeast
cell
condit
uv
irradi
share
common
hallmark
defin
age
chang
unfortun
mani
reason
failur
homeostasi
could
count
age
research
wish
use
precis
definit
often
cite
strehler
consid
defin
featur
age
univers
progress
intrins
degen
evolutionari
rational
age
clearli
compromis
organism
surviv
medawar
recognis
wild
popul
extrins
mortal
major
compon
total
mortal
result
chronolog
old
anim
rare
even
organ
question
show
age
process
condit
earli
act
deleteri
mutat
strongli
select
sinc
affect
abil
organ
pass
gene
next
gener
harm
mutat
occur
later
life
cours
expos
select
pressur
age
therefor
develop
result
accumul
lateact
deleteri
mutat
antagonist
pleiotropi
theori
age
william
extend
medawar
initi
observ
age
depend
reproduct
postul
exist
pleiotrop
gene
ie
allel
differ
effect
surviv
organ
life
cours
gene
exert
favour
effect
earli
life
fecund
effect
natur
select
strong
deleteri
one
later
life
effect
natur
select
weak
predict
antagonist
pleiotropi
eg
fertil
longev
neg
correl
confirm
experi
use
fruit
fli
drosophila
melanogast
postpon
reproduct
increas
life
expect
convers
decreas
fertil
observ
longliv
fli
rose
charlesworth
pleiotrop
effect
occur
level
individu
gene
eg
play
key
role
cellular
anticanc
mechan
cost
suppress
stem
cell
prolifer
surviv
also
level
global
process
immun
antagonist
pleiotropi
concept
extens
appli
age
immun
system
interest
system
exercis
tradeoff
one
hand
must
defend
organ
extrins
threat
ie
pathogen
time
must
face
inward
suppress
malign
avoid
autoimmun
addit
complex
organ
immun
system
must
distinguish
benefici
potenti
pathogen
organ
microbiom
known
extrins
challeng
immun
system
compromis
evolutionari
fit
freeliv
old
anim
young
one
palacio
et
al
contrast
intrins
tradeoff
face
later
life
organ
far
less
intens
studi
antagonist
pleiotropi
predict
vigor
immun
respons
earli
life
would
select
environ
signific
compon
extrins
mortal
due
infecti
diseas
incid
eg
human
popul
epidemiolog
transit
wild
popul
anim
today
select
would
occur
even
immun
respons
deleteri
older
organ
data
exist
consist
pleiotrop
effect
human
innat
immun
system
capac
mount
inflammatori
respons
genet
determin
man
proinflammatori
cytokin
profil
associ
increas
surviv
follow
meningococc
sepsi
young
whilst
contrast
cytokin
genotyp
relat
increas
antiinflammatori
profil
also
posit
associ
longev
protect
popul
westendorp
et
al
june
studi
ghana
compar
popul
area
recent
access
clean
water
still
live
immunolog
challeng
environ
produc
drink
pathogencontain
water
river
well
research
found
clear
pleiotrop
effect
proinflammatori
allel
interleukin
il
protect
carrier
excess
mortal
advers
environ
produc
somewhat
increas
agespecif
mortal
affluent
area
boef
et
al
kuninga
et
al
imagin
particip
also
specul
life
cours
inflammatori
stimuli
microbi
pathogen
sourc
like
becom
increasingli
compound
endogen
stimuli
one
plausibl
sourc
endogen
nois
senescenceassoci
secretori
phenotyp
spectrum
proinflammatori
cytokin
secret
senesc
cell
perman
exit
cell
cycl
known
accumul
signific
number
advanc
age
compromis
health
statu
tchkonia
et
al
alongsid
damageassoci
molecular
pattern
damp
also
becom
frequent
advanc
age
damp
protein
usual
sequest
cytosol
releas
cell
necrosi
result
rang
agerel
condit
eg
stroke
myocardi
infarct
interestingli
damp
includ
two
preform
poorli
secret
member
famili
eg
also
made
senesc
cell
indic
potenti
overlap
senesc
steril
inflamm
berdahaddad
et
al
burton
et
al
clearli
highli
proinflammatori
cytokin
profil
earli
life
deleteri
effect
later
life
cours
could
aggrav
degen
process
later
life
pleiotrop
fashion
ultim
contribut
chronic
inflammatori
state
data
consist
idea
notabl
proinflammatori
cytokin
profil
risk
factor
cognit
declin
wikbi
et
al
continu
exposur
damp
steadi
increas
senesc
cell
also
potenti
produc
dysregul
inflammatori
network
result
state
chronic
inflamm
consortium
member
specul
lowgrad
chronic
inflamm
seen
age
mammal
qv
result
chronic
antigen
stress
also
complex
combin
genet
determin
compet
produc
proinflammatori
cytokin
profil
senesc
cell
damp
idea
readili
testabl
long
known
grow
older
associ
increas
incid
recognis
diseas
entiti
eg
type
ii
diabet
arthrosi
cardiovascular
diseas
well
increas
suscept
infecti
diseas
give
rise
chickenandegg
etiolog
question
whether
age
caus
diseas
whether
diseas
constitut
age
process
also
import
emphasis
immun
paramet
measur
young
human
today
potenti
differ
introduc
formal
possibl
chang
seen
crosssect
human
studi
result
differenti
environment
exposur
rather
biolog
age
said
longitudin
studi
far
perform
consist
hypothesi
age
chang
time
individu
inde
occur
howev
studi
mostli
except
age
individu
reveal
larg
scale
interindividu
heterogen
age
trajectori
even
amongst
success
age
peopl
justic
physiolog
may
better
simpli
think
mechan
immun
declin
group
immunemedi
effect
lead
decreas
life
expect
increas
age
thought
earli
gerontologist
senesc
whole
rather
attempt
classifi
true
chang
underli
diseas
larg
artifici
distinct
individu
declin
may
also
result
adapt
process
shape
immun
system
better
deal
particular
organ
specif
past
current
challeng
eg
persist
pathogen
infect
earli
attempt
identifi
true
agerel
chang
immunogerontolog
studi
develop
senieur
protocol
ligthart
et
al
protocol
defin
select
criteria
set
limit
diseas
druginduc
chang
immun
system
attempt
minimis
effect
underli
diseas
mani
chang
immun
function
previous
attribut
age
less
pronounc
optim
healthi
elderli
peopl
select
senieur
protocol
individu
rare
leiden
inhabit
age
year
older
fulfil
criteria
senieurship
found
thu
although
rational
develop
senieur
may
philosoph
question
protocol
proven
use
demonstr
elderli
exhibit
immun
valu
similar
modern
young
peopl
consist
success
immun
age
thu
practic
research
perspect
press
need
understand
account
small
fraction
except
healthi
peopl
whatev
reason
happi
state
genet
background
lifestyl
pathogen
burden
consortium
member
consid
aspect
contribut
need
studi
stratifi
manner
compar
age
success
note
limit
previou
studi
appear
invers
relationship
immun
statu
respons
vaccin
health
longev
least
partli
due
immun
system
becom
less
effect
individu
level
advanc
age
humor
cellular
immun
respons
differ
elderli
individu
believ
repres
chang
lead
increas
frequenc
sever
infecti
diseas
reduc
protect
vaccin
innat
natur
immun
first
line
defenc
preced
antigenspecif
humor
b
cell
cellular
cell
respons
play
crucial
role
prevent
microbi
invas
age
significantli
impair
phenotyp
function
cell
innat
immun
system
neutrophil
monocytemacrophag
dendrit
cell
nk
cell
lead
decreas
activ
chemotaxi
phagocytosi
intracellular
kill
pathogen
solana
et
al
age
also
characteris
dysregul
inflammatori
antiinflammatori
network
result
lowgrad
chronic
proinflammatori
statu
sometim
term
inflammag
persist
lowgrad
innat
immun
activ
thu
agerel
chang
innat
immun
appear
reflect
system
remodel
possibl
consequ
immunolog
histori
rather
simpli
decreas
function
age
affect
humor
immun
respons
quantit
qualit
specif
class
antibodi
produc
chang
chang
humor
immun
respons
age
significantli
contribut
increas
suscept
elderli
infecti
diseas
reduc
protect
effect
vaccin
decreas
abil
age
individu
produc
highaffin
protect
antibodi
respons
infecti
agent
result
least
part
compromis
b
cell
function
may
suffer
lack
optim
cell
help
age
intrins
chang
b
cell
also
occur
signific
impact
antibodi
product
chang
includ
decreas
activationinduc
cytidin
deaminas
aid
enzym
respons
class
switch
recombin
transcript
factor
regul
express
aid
also
regul
somat
hypermut
respons
product
highaffin
protect
antibodi
whose
product
impair
age
cancro
et
al
easili
recognis
differ
young
old
peopl
immun
paramet
concern
cell
arm
adapt
immun
particularli
cell
respons
amongst
thing
lyse
virusinfect
host
cell
development
determin
thymic
involut
begin
puberti
sourc
cell
adult
greatli
reduc
gener
number
frequenc
cell
lower
adult
children
far
lower
old
adult
like
due
three
factor
thymic
involut
result
lower
cell
output
ii
pathogen
encount
cell
earli
life
differenti
antipathogen
effector
cell
convers
small
fraction
memori
cell
maintain
immun
protect
pathogen
throughout
life
iii
homeostat
prolifer
peripher
cell
pool
result
one
hallmark
immun
age
reduct
cell
concomit
increas
memoryeffector
cell
one
main
drive
forc
ageassoci
chang
cell
phenotyp
antigen
exposur
across
lifespan
subsum
period
acut
infect
chronic
stimul
persist
viral
infect
human
infect
betaherpesviru
cytomegaloviru
cmv
appear
major
player
latter
context
particular
viru
even
close
relat
herp
virus
effect
known
begin
intens
investig
solana
et
al
cmv
pathogen
extrem
circumst
neonat
infect
iatrogen
immunosuppress
aid
howev
uniqu
amongst
herp
virus
far
know
uniqu
amongst
immun
challeng
even
includ
alloreact
cmv
infect
result
commit
signific
immun
resourc
immunosurveil
order
maintain
viru
latent
state
level
commit
increas
age
signific
portion
cell
devot
cmv
suppress
mark
consequ
system
physiolog
thu
cmv
driver
accumul
latestag
differenti
cell
distinguish
featur
immun
risk
profil
predict
mortal
longitudin
studi
elderli
may
respons
emerg
consensu
neg
surviv
consequ
cmv
infect
even
earlier
life
also
reflect
impact
cmv
infect
respons
influenza
vaccin
slowli
approach
mechanist
explan
deleteri
effect
may
mediat
gain
appreci
interindividu
differ
may
inform
manipul
improv
clinic
outcom
derhovanessian
et
al
bartlett
et
al
chronic
exposur
virus
cmv
clearli
either
caus
acceler
immunosenesc
result
increas
suscept
infect
mani
develop
countri
chronic
infect
viral
bacteri
parasitolog
frequent
persist
develop
countri
exampl
young
subsaharan
african
adult
show
significantli
elev
serum
igg
level
mgml
compar
young
european
mgml
elev
level
chronic
immun
stimul
probabl
caus
least
part
high
preval
helminth
malaria
infect
obvious
depend
local
pathogen
presenc
like
place
individu
live
entir
live
condit
significantli
increas
risk
immun
exhaust
opportunist
infect
effect
method
prevent
infecti
diseas
vaccin
howev
effect
vaccin
markedli
differ
individu
differ
age
goodwin
et
al
mcelhaney
exampl
case
season
influenza
vaccin
evid
elderli
individu
routin
receiv
vaccin
still
contract
infect
secondari
complic
lead
physic
debilit
hospitalis
exacerb
underli
medic
condit
death
face
scenario
imagin
particip
saw
need
obtain
better
knowledg
mechan
induct
develop
mainten
protect
immun
elderli
respons
vaccin
emerg
reemerg
infecti
diseas
unsurprisingli
influenza
pneumococcu
herp
zoster
consid
prioriti
pathogen
imagin
particip
new
emerg
pathogen
dengu
fever
also
seen
import
given
global
health
risk
pose
older
peopl
vaccin
still
requir
provid
optim
protect
elderli
although
influenza
vaccin
current
provid
protect
must
reformul
everi
year
time
lag
spread
pandem
viru
avail
vaccin
worryingli
lengthi
newli
emerg
infecti
diseas
swineorigin
avian
influenza
sever
acut
respiratori
syndrom
dengu
fever
constant
threat
bacteri
infect
recurr
salmonella
outbreak
food
industri
costli
societi
howev
vaccin
gener
origin
develop
young
adult
preexist
immun
target
popul
consid
imagin
particip
note
previou
exposur
influenza
strain
larg
age
depend
impli
ideal
influenza
vaccin
strain
composit
dosag
differ
young
elderli
popul
import
preexist
immun
influenza
best
illustr
rel
low
impact
swineorigin
influenza
viru
epidem
middl
age
elderli
subject
previous
expos
influenza
virus
verma
et
al
may
adjuv
influenza
hatz
et
al
highdos
influenza
vaccin
show
improv
immunogen
elderli
subject
may
confer
better
protect
compar
standard
influenza
vaccin
cool
et
al
one
difficulti
develop
effect
vaccin
lack
predictor
efficaci
although
sign
progress
area
derhovanessian
et
al
need
differ
individu
show
differ
respons
vaccin
everi
vaccin
individu
mount
protect
cellular
humor
immun
respons
emerg
immunolog
indic
determin
like
respond
level
antigenpres
cell
van
duin
et
al
term
measur
preexist
cell
reactiv
share
influenza
antigen
derhovanessian
et
al
recent
advanc
molecular
biolog
proteom
made
possibl
genomewid
measur
level
transcript
splice
variant
noncod
rna
metabolit
protein
epigenet
chang
germlin
polymorph
thu
open
new
frontier
vaccinolog
highthroughput
multiom
data
use
construct
predict
model
interact
biolog
compon
pathogenhost
system
obtain
global
pictur
immun
respons
vaccin
human
identifi
earli
gene
signatur
correl
predict
later
immun
respons
vaccin
approach
allow
identif
predictor
vaccin
respons
influenza
yellow
fever
far
howev
yet
provid
mechanist
insight
given
vaccin
elicit
protect
immun
therefor
multibiomark
characteris
respond
nonrespond
warrant
imagin
meet
wide
rang
potenti
biomark
propos
includ
cellular
biomark
eg
b
lymphocyt
monocytemacrophag
dendrit
cell
neutrophil
molecular
biomark
eg
cytokin
antibodi
produc
vitro
transcript
factor
system
biomark
eg
cmv
load
proand
antiinflammatori
cytokin
level
hormon
microrna
mitdna
microbi
dna
metabolitesnutrit
futur
research
biomark
area
thu
potenti
first
stratifi
older
popul
improv
percentag
older
respond
declin
function
central
nervou
system
one
seriou
aspect
age
process
one
immun
system
tradit
consid
play
major
role
sinc
cn
immuneprivileg
site
yeoman
et
al
howev
fascin
link
two
system
emerg
turn
open
new
prospect
therapeut
advanc
data
schwartz
group
suggest
function
cellmedi
immun
requir
mainten
hippocampusdepend
spatial
memori
ronharel
et
al
immunedefici
mice
show
impair
spatial
memori
phenotyp
rescu
immun
reconstitut
convers
compromis
immun
system
young
mice
also
impair
spatial
memori
research
shown
memori
loss
age
mice
attribut
agerel
attenu
immun
respons
phenotyp
could
rescu
expans
exist
cell
repertoir
excit
observ
suggest
immun
system
play
major
previous
unsuspect
role
mainten
repair
normal
cn
schwartz
et
al
schwartz
shechter
explor
crosstalk
two
system
context
immunosenesc
potenti
yield
excit
result
phenotyp
senesc
cell
clearli
potenti
contribut
chronic
inflamm
characteris
later
life
broader
question
senesc
cell
proinflammatori
littl
consid
year
ago
burton
amongst
first
propos
inflammatori
phenotyp
might
play
function
role
signal
facilit
immun
clearanc
almost
simultan
krizhanovski
colleagu
demonstr
natur
killer
cell
preferenti
kill
senescentactiv
stellat
cell
vitro
vivo
facilit
resolut
liver
fibrosi
krizhanovski
et
al
clearanc
recent
shown
primarili
depend
granul
exocytosi
nk
cell
rather
deathreceptormedi
due
upregul
decoy
death
receptor
senesc
target
sagiv
et
al
howev
sinc
phenotyp
senesc
cell
variabl
across
tissu
may
prematur
assum
bia
pathway
usag
global
phenomenon
involv
nk
cell
senesc
cell
clearanc
suggest
major
new
role
immun
system
remodel
multipl
organ
system
later
life
interestingli
come
light
time
longstand
view
adapt
immun
system
abl
build
immunolog
memori
reevalu
memori
properti
nk
cell
monocyt
macrophag
mani
way
exemplar
innat
immun
recent
describ
phenomenon
known
train
immun
netea
et
al
becom
clear
set
point
product
inflammatori
cytokin
innat
immun
system
modul
either
bcg
vaccin
infect
candida
albican
kleinnijenhui
et
al
quintin
et
al
chang
appear
epigenet
persist
year
play
immun
senesc
remain
unclear
thu
time
probabl
right
role
immun
system
age
simpli
imagin
reimagin
